Synergy Immunotherapeutics (IMT) is committed to serving those in need by creating highly efficacious therapeutics to treat cancer.   Synergy IMT focuses primarily on targeting tumor restricted antigens discovered at Synergy IMT.  Synergy IMT creates antibody-based therapeutics, antibody drug-conjugates (ADC) and innovative multivalent recombinant proteins to kill tumor cells and induce or revitalize an anti-tumor immune response.